Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

S. Tewari, Krishnansu; A. Burger, Robert; Enserro, Danielle; M. Norquist, Barbara; M. Swisher, Elizabeth; F. Brady, Mark; A. Bookman, Michael; F. Fleming, Gini; Huang, Helen; D. Homesley, Howard; M. Fowler, Jeffrey; E. Greer, Benjamin; Boente, Matthew; X. Liang, Sharon; Ye, Chenglin; Bais, Carlos; M. Randall, Leslie; K. Chan, John; Stuart Ferriss, J.; L. Coleman, Robert; Aghajanian, Carol; J. Herzog, Thomas; J. DiSaia, Philip; J. Copeland, Larry; S. Mannel, Robert; J. Birrer, Michael; J. Monk, Bradley

doi:10.1200/jco.19.01009

Public

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Published in Journal of Clinical Oncology • Jun 19, 2019

Authors:

Krishnansu S. Tewari

Robert A. Burger

Danielle Enserro

Abstract

PURPOSE We report the final, protocol-specified analysis of overall survival (OS) in GOG-0218, a phase III, randomized trial of bevacizumab in women with newly diagnosed ovarian, fallopian tube, or primary peritoneal carcinoma. METHODS A total of 1,873 women with incompletely resected stage III to I...

Subject

Bevacizumab

Medicine

Carboplatin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!